Clinical Trial Update: Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome [Phase 3]

View source ↗

Summary

Open-label Phase 3 extension study of pramipexole in children and adolescents with Tourette syndrome was terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Tourette Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2010-12-17